Plain-English translation of NCT07443059 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is a Phase 1 trial testing a new medication called , which is being developed to help with weight loss and obesity. The study will give participants a single injection of the medication and carefully monitor how their bodies process it. Because kidney health can affect how medications work, this trial includes people with normal kidney function, mild kidney problems, moderate kidney problems, and severe kidney problems—so researchers can see if kidney health changes how the body handles this treatment.
When kidneys don't work as well, they may affect how medications are broken down and removed from the body. This trial exists to make sure this medication is safe and effective for everyone, including people whose kidneys aren't working at full capacity.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic to receive a single injection of the medication under your skin. The study will then monitor you closely over a set period to track how your body processes the medication through blood tests and other measurements. Your kidney function level will determine which group you join, but all participants will receive the same single dose and have similar follow-up visits to ensure your safety.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China